drugset / Trial / NCT03562611

Postoperative Pain and Discomfort After Orbital Decompression

NCT03562611

Completed 63 enrolled Sun Yat-sen University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the postoperative pain and discomfort using flurbiprofen axetil or nalbuphine administration after orbital decompression under general anesthesia.

Timeline

Start
2018-06-08
Primary completion
2018-09-08
Completion
2018-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Nalbuphine Small molecule 0.1 mg/kg Intravenous
Subject flurbiprofen axetil Other / unclassified 100 mg Intravenous

Indications

No indication recorded.